Caesalpinia sappan reduces the stemness of breast cancer stem cells involving the elevation of intracellular reactive oxygen species

Caesalpinia sappan reduces the stemness of breast cancer stem cells involving the elevation of intracellular reactive oxygen species

Background and purpose: Breast cancer stem cells (BCSCs) as a kind of tumor cells are able to regenerate themselves, leading to apoptosis resistance and cancer relapse. It was reported that BCSCs contain lower levels of reactive oxygen species (ROS) associated with stemness capability. Caesalpinia s...

Full description

Bibliographic Details
Main Authors:	Riris Istighfari Jenie, Nur Dina Amalina, Adam Hermawan, Meiny Suzery, Agung Putra, Edy Meiyanto
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Series:	Research in Pharmaceutical Sciences
Subjects:	cancer stem cell; cd44; cd24; mda-mb-231; ros; stemness marker.
Online Access:	http://www.rpsjournal.net/article.asp?issn=1735-5362;year=2023;volume=18;issue=6;spage=708;epage=721;aulast=Jenie

Similar Items

Evaluation of Genistein Effect on Invasion of Breast Cancer Stem Cell-Like Cells
by: Farnaz Malekmarzban, et al.
Published: (2018-06-01)

CD44 expression changes in MDA-MB-231 cell line of breast cancer after exposure to 2-D clinorotation
by: Zahra Hajebrahimi, et al.
Published: (2021-12-01)

Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses
by: Sebastien Taurin, et al.
Published: (2020-12-01)

Tartrate-resistant acid phosphatase (TRAP/ACP5) promotes metastasis-related properties via TGFβ2/TβR and CD44 in MDA-MB-231 breast cancer cells
by: Anja Reithmeier, et al.
Published: (2017-09-01)

Irradiation and conditioned media from human umbilical cord stem cells suppress epithelial-mesenchymal transition biomarkers in breast cancer cells
by: Rahil Ghanbarnasab Behbahani, et al.
Published: (2023-04-01)

Genetic profiling of different phenotypic subsets of breast cancer stem cells (BCSCs) in breast cancer patients
by: Abdel-Rahman N. Zekri, et al.
Published: (2022-12-01)

Cancer stem cell markers in intraoral minor salivary gland tumors
by: Benay Yıldırım, et al.
Published: (2022-06-01)

Meme kanseri hücre hatlarında propranolol ve paklitakselin anjiyogenez üzerine etkisi
by: Fatma Şimşek, et al.
Published: (2019-03-01)

In Vitro Antimicrobial Activity of Isopimarane-Type Diterpenoids
by: Vera M. S. Isca, et al.
Published: (2020-09-01)

Reprimo as a modulator of cell migration and invasion in the MDA-MB-231 breast cancer cell line
by: Kurt Buchegger, et al.

Synthesis of the C<sub>3</sub> and C<sub>1</sub> Constitutional Isomers of Trifluorosubphthalocyanine and Their Fluorescence within MDA-MB-231 Breast Tumor Cells
by: Rosemarie L. Calandrino, et al.
Published: (2019-10-01)

A New Approach for Loading Anticancer Drugs Into Mesenchymal Stem Cell-Derived Exosome Mimetics for Cancer Therapy
by: Senthilkumar Kalimuthu, et al.
Published: (2018-09-01)

CD44 related stemness maneuvers oral squamous cell carcinoma biology
by: Ankita Tandon, et al.
Published: (2022-01-01)

Cancer stem cell markers ALDH1 and CD44+/CD24- phenotype and their prognosis impact in invasive ductal carcinoma
by: Iris Rabinovich, et al.
Published: (2018-09-01)

Isolation and Characterization of Human Umbilical Cord Wharton’s jelly Stem Cells
by: Saber Zahri, et al.
Published: (2013-04-01)

Immunological Response against Breast Lineage Cells Transfected with Human Papillomavirus (HPV)
by: Daffany Luana Santos, et al.
Published: (2024-04-01)

Stem cells from glomerulus to distal tubule: a never-ending story?
by: Melania Puddu, et al.
Published: (2016-08-01)

Amino acid profile changes during enrichment of spheroid cells with cancer stem cell properties in MCF‐7 and MDA‐MB‐231 cell lines
by: Zahra Ghanbari Movahed, et al.
Published: (2023-05-01)

A Systematic Review to Clarify the Prognostic Values of CD44 and CD44+CD24- Phenotype in Triple-Negative Breast Cancer Patients: Lessons Learned and The Road Ahead
by: Mahdi Abdoli Shadbad, et al.
Published: (2021-08-01)

Detecting heterogeneity in and between breast cancer cell lines
by: Yang Shen, et al.
Published: (2020-02-01)

The v8-10 variant isoform of CD44 is selectively expressed in the normal human colonic stem cell niche and frequently is overexpressed in colon carcinomas during tumor development
by: Bruce M. Boman, et al.
Published: (2023-12-01)

Evaluation of CD44 and CD133 as markers of liver cancer stem cells in Egyptian patients with HCV-induced chronic liver diseases versus hepatocellular carcinoma
by: Mohammed Saeed Rozeik, et al.
Published: (2017-07-01)

1,2,3,4,6-Penta-O-galloyl-β-D-glucose Inhibits CD44v3, a cancer stem cell marker, by regulating its transcription factor, in human pancreatic cancer cell line
by: Eun-Young Kim, et al.
Published: (2022-11-01)

Inhibitory Effects of Tangeretin, a Citrus Peel-Derived Flavonoid, on Breast Cancer Stem Cell Formation through Suppression of Stat3 Signaling
by: Yu-Chan Ko, et al.
Published: (2020-06-01)

A New Heteroleptic Zn(II) Complex with Schiff Bases Sensitizes Triple-Negative Breast Cancer Cells to Doxorubicin and Paclitaxel
by: Raiane Aparecida dos Santos Machado, et al.
Published: (2024-12-01)

Coumarin Sulfonamides and Amides Derivatives: Design, Synthesis, and Antitumor Activity In Vitro
by: Jing Zhang, et al.
Published: (2021-02-01)

دراسة تأثیر مركبات ثیازولیة جدیدة في الخط الخلوي السرطاني MDA-MB-231
by: لوناالنكود, et al.
Published: (2023-01-01)

Comparison of the effect of rhodium citrate-associated iron oxide nanoparticles on metastatic and non-metastatic breast cancer cells
by: Natalia Lemos Chaves, et al.
Published: (2019-09-01)

Enhancement of paclitaxel and doxorubicin cytotoxicity in breast cancer cell lines in combination with piperine treatment and analysis of expression of autophagy and apoptosis genes
by: Pushpa Ragini, et al.
Published: (2014-04-01)

Impact of stem cell marker expression on recurrence of TACE-treated hepatocellular carcinoma post liver transplantation
by: Zeng Zhen, et al.
Published: (2012-12-01)

Heterogeneity of Cancer Stem Cells in Tumorigenesis, Metastasis, and Resistance to Antineoplastic Treatment of Head and Neck Tumours
by: Nicola Cirillo, et al.
Published: (2021-11-01)

EXPRESSION OF CD44 AND CD24 MARKERS IN BIOPSY SAMPLES OF TRIPLE NEGATIVE BREAST CANCER PATIENTS BEFORE TREATMENT
by: S. G. Smirnova, et al.
Published: (2020-09-01)

PPARα-Selective Antagonist GW6471 Inhibits Cell Growth in Breast Cancer Stem Cells Inducing Energy Imbalance and Metabolic Stress
by: Vanessa Castelli, et al.
Published: (2021-01-01)

Biological characteristics of a sub-population of cancer stem cells from two triple-negative breast tumour cell lines
by: Javier Enciso-Benavides, et al.
Published: (2021-06-01)

COSMC-Regulated O-Glycosylation: A Bioinformatics-Driven Biomarker Identification for Stratifying Glioblastoma Stem Cell Subtypes
by: Sara Sadat Aghamiri, et al.
Published: (2024-12-01)

FEATURES OF EXPRESSION OF CD133 AND CD44 MARKERS OF TUMOR STEM CELLS WITH METASTATIC AND NON-METASTATIC GASTRIC CANCER
by: A. B. Sagakyants, et al.
Published: (2021-03-01)

Comparison of CD44 and CD14 Surface Markers in Adipose-Derived Stem Cells and Differentiated Chondrocytes during Chondrogenesis
by: Ronak Zarei, et al.
Published: (2014-07-01)

Cancer stem cells are prevalent in the basal-like 2 and mesenchymal triple-negative breast cancer subtypes in vitro
by: Maxim Olsson, et al.
Published: (2023-09-01)

An Old Idea Tackling a New Problem: Targeted Toxins Specific for Cancer Stem Cells
by: Daniel A. Vallera, et al.
Published: (2013-01-01)

Immunohistochemical Expression of Adult Stem Markers in Salivary Mucoepidermoid Carcinoma with Relevance to Molecular Profiling: Any Prognostic Implications and Oncogenic Mechanisms Eked?
by: Ebtissam Alerraqi, et al.
Published: (2024-12-01)